Deal history
3 participations| Date | Company | Round | Raised | Post-money | Role |
|---|---|---|---|---|---|
| Sep 2026 | Superluminal Medicines | Series B | ▮ | ▮ | ▮ |
| Feb 2026 | Novig | Series B | ▮ | ▮ | ▮ |
| Aug 2025 | Novig | Series A | ▮ | ▮ | ▮ |
All 3 deals — valuations, dates and lead flags are a member feature Membership and data by Private Market View | |||||
Investment activity
Perceptive Advisors joined 3 recorded rounds in the last two years (2 in the last 12 months). By year: 2 in 2026 and 1 in 2025. 1 round landed in the last 90 days. Perceptive Advisors most often invests alongside Gaingels (2 shared rounds) and NFX (2 shared rounds). Most recently: Superluminal Medicines (Series B, Sep 2026) and Novig (Series B, Feb 2026).
Free account
See more of the book
- ·The top 10 names in the book — of 34 recorded positions
- ·Watchlist + alerts for Perceptive Advisors's activity